Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report

Author:

Comeau Anne Marie1,Accurso Frank J.2,White Terry B.3,Campbell Preston W.3,Hoffman Gary4,Parad Richard B.156,Wilfond Benjamin S.78,Rosenfeld Margaret9,Sontag Marci K.10,Massie John11,Farrell Philip M.12,O'Sullivan Brian P.13

Affiliation:

1. New England Newborn Screening Program and Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts

2. Department of Pediatrics, Mike McMorris Cystic Fibrosis Research and Treatment Center, University of Colorado Health Sciences Center and Children's Hospital, Denver, Colorado

3. Cystic Fibrosis Foundation, Bethesda, Maryland

4. State Laboratory of Hygiene

5. Department of Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts

6. Department of Newborn Medicine, Children's Hospital, Boston, Massachusetts

7. Social and Behavioral Research Branch, National Human Genome Research Institute

8. Department of Clinical Bioethics, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

9. Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington

10. Department of Preventive Medicine, University of Colorado Health Sciences Center, Denver, Colorado

11. Department of Respiratory Medicine, Royal Children's Hospital, Melbourne, Australia

12. Department of Pediatrics, University of Wisconsin, Madison, Wisconsin

13. Department of Pediatrics, University of Massachusetts Medical Center, Worcester, Massachusetts

Abstract

Newborn screening for cystic fibrosis offers the opportunity for early intervention and improved outcomes. This summary, resulting from a workshop sponsored by the Cystic Fibrosis Foundation to facilitate implementation of widespread high quality cystic fibrosis newborn screening, outlines the steps necessary for success based on the experience of existing programs. Planning should begin with a workgroup composed of those who will be responsible for the success of the local program, typically including the state newborn screening program director and cystic fibrosis care center directors. The workgroup must develop a screening algorithm based on program resources and goals including mechanisms available for sample collection, regional demographics, the spectrum of cystic fibrosis disease to be detected, and acceptable failure rates of the screen. The workgroup must also ensure that all necessary guidelines and resources for screening, diagnosis, and care be in place prior to cystic fibrosis newborn screening implementation. These include educational materials for parents and primary care providers; systems for screening and for providing diagnostic testing and counseling for screen-positive infants and their families; and protocols for care of this unique population. This summary explores the benefits and risks of various screening algorithms, including complex situations that can occur involving unclear diagnostic results, and provides guidelines and sample materials for state newborn screening programs to develop and implement high quality screening for cystic fibrosis.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3